Validation of housekeeping gene and impact on normalized gene expression in clear cell Renal Cell Carcinoma: Critical reassessment of YBX3/ZONAB/CSDA expression

BMC Molecular Biology

Volumn 15, Issue , 2014, Pages

  Dupasquier, Sébastien ^a   Delmarcelle, Anne Sophie ^a   Marbaix, Etienne ^a,b   Cosyns, Jean Pierre ^b   Courtoy, Pierre J ^a   Pierreux, Christophe E ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BETA ACTIN; CYCLIN D1; CYCLINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PEPTIDYLPROLYL ISOMERASE; PEROXIDASE; RIBOSOMAL PROTEIN L27; RIBOSOMAL PROTEIN S13; RIBOSOME PROTEIN; RNA 18S; RNA POLYMERASE II; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; IN VITRO STUDY; KIDNEY CARCINOMA; MALE; MIDDLE AGED; MYELOID LEUKEMIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA ISOLATION; STRATIFICATION; 18S RIBOSOMAL RNA GENE; BETA 2 MICROGLOBULIN GENE; BETA ACTIN GENE; CANCER GRADING; CANCER RISK; CANCER TISSUE; COLD SHOCK DOMAIN PROTEIN A GENE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC STABILITY; GENETIC VARIABILITY; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE GENE; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; IN VIVO STUDY; REFERENCE VALUE; RISK ASSESSMENT; TUMOR GENE; VALIDATION STUDY; Y BOX BINDING PROTEIN 3 GENE; ZONULA OCCLUDENS 1 ASSOCIATED NUCLEIC ACID BINDING PROTEIN GENE;

ACTINS; ADULT; AGED; CARCINOMA, RENAL CELL; CCAAT-ENHANCER-BINDING PROTEINS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ESSENTIAL; HEAT-SHOCK PROTEINS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RIBOSOMAL PROTEINS;

EID: 84901652491     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-15-9     Document Type: Article

References (68)

1. Hendriks-Balk MC, Michel MC, Alewijnse AE. Pitfalls in the normalization of real-time polymerase chain reaction data. Basic Res Cardiol 2007, 102(3):195-197. 10.1007/s00395-007-0649-0, 2779446, 17370033.
2. Rocha-Martins M, Njaine B, Silveira MS. Avoiding pitfalls of internal controls: validation of reference genes for analysis by qRT-PCR and Western blot throughout rat retinal development. PLoS One 2012, 7(8):e43028. 10.1371/journal.pone.0043028, 3423434, 22916200.
3. Thellin O, Zorzi W, Lakaye B, De Borman B, Coumans B, Hennen G, Grisar T, Igout A, Heinen E. Housekeeping genes as internal standards: use and limits. J Biotechnol 1999, 75(2-3):291-295.
4. Guenin S, Mauriat M, Pelloux J, Van Wuytswinkel O, Bellini C, Gutierrez L. Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references. J Exp Bot 2009, 60(2):487-493. 10.1093/jxb/ern305, 19264760.
5. Selvey S, Thompson EW, Matthaei K, Lea RA, Irving MG, Griffiths LR. Beta-actin-an unsuitable internal control for RT-PCR. Mol Cell Probes 2001, 15(5):307-311. 10.1006/mcpr.2001.0376, 11735303.
6. Ruan W, Lai M. Actin, a reliable marker of internal control?. Clin Chim Acta 2007, 385(1-2):1-5.
7. Caradec J, Sirab N, Keumeugni C, Moutereau S, Chimingqi M, Matar C, Revaud D, Bah M, Manivet P, Conti M, Loric S. 'Desperate house genes': the dramatic example of hypoxia. Br J Cancer 2010, 102(6):1037-1043. 10.1038/sj.bjc.6605573, 2844028, 20179706.
8. Caradec J, Sirab N, Revaud D, Keumeugni C, Loric S. Is GAPDH a relevant housekeeping gene for normalisation in colorectal cancer experiments?. Br J Cancer 2010, 103(9):1475-1476. 10.1038/sj.bjc.6605851, 2990595, 20859286.
9. Mansur NR, Meyer-Siegler K, Wurzer JC, Sirover MA. Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells. Nucleic Acids Res 1993, 21(4):993-998. 10.1093/nar/21.4.993, 309234, 8451199.
10. Vila MR, Nicolas A, Morote J, de I, Meseguer A. Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction. Cancer 2000, 89(1):152-164. 10.1002/1097-0142(20000701)89:1<152::AID-CNCR20>3.0.CO;2-T, 10897012.
11. Sirover MA. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology. J Cell Biochem 1997, 66(2):133-140. 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.0.CO;2-R, 9213215.
12. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004, 64(15):5245-5250. 10.1158/0008-5472.CAN-04-0496, 15289330.
13. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: bestkeeper-excel-based tool using pair-wise correlations. Biotechnol Lett 2004, 26(6):509-515.
14. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3(7). research0034.1-0034.11.
15. Balda MS, Garrett MD, Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 2003, 160(3):423-432. 10.1083/jcb.200210020, 2172662, 12566432.
16. Sourisseau T, Georgiadis A, Tsapara A, Ali RR, Pestell R, Matter K, Balda MS. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol 2006, 26(6):2387-2398. 10.1128/MCB.26.6.2387-2398.2006, 1430269, 16508013.
17. Lima WR, Parreira KS, Devuyst O, Caplanusi A, N'Kuli F, Marien B, Van Der Smissen P, Alves PM, Verroust P, Christensen EI, Terzi F, Matter K, Balda MS, Pierreux CE, Courtoy PJ. ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells. J Am Soc Nephrol 2010, 21(3):478-488. 10.1681/ASN.2009070698, 2831853, 20133480.
18. Nie M, Balda MS, Matter K. Stress- and Rho-activated ZO-1-associated nucleic acid binding protein binding to p21 mRNA mediates stabilization, translation, and cell survival. Proc Natl Acad Sci U S A 2012, 109(27):10897-10902. 10.1073/pnas.1118822109, 3390842, 22711822.
19. Tobita H, Kajino K, Inami K, Kano S, Yasen M, Imamura O, Kinoshita Y, Hino O. Gene expression profile of DNA binding protein A transgenic mice. Int J Oncol 2006, 29(3):673-679.
20. Hayashi J, Kajino K, Umeda T, Takano S, Arakawa Y, Kudo M, Hino O. Somatic mutation and SNP in the promoter of dbpA and human hepatocarcinogenesis. Int J Oncol 2002, 21(4):847-850.
21. Arakawa Y, Kajino K, Kano S, Tobita H, Hayashi J, Yasen M, Moriyama M, Hino O. Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis. Biochem Biophys Res Commun 2004, 322(1):297-302. 10.1016/j.bbrc.2004.04.208, 15313206.
22. Yasen M, Kajino K, Kano S, Tobita H, Yamamoto J, Uchiumi T, Kon S, Maeda M, Obulhasim G, Arii S, Hino O. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma. Clin Cancer Res 2005, 11(20):7354-7361. 10.1158/1078-0432.CCR-05-1027, 16243807.
23. Wang GR, Zheng Y, Che XM, Wang XY, Zhao JH, Wu KJ, Zeng J, Pan CE, He DL. Upregulation of human DNA binding protein A (dbpA) in gastric cancer cells. Acta Pharmacol Sin 2009, 30(10):1436-1442. 10.1038/aps.2009.137, 19749785.
24. Matsumoto G, Yajima N, Saito H, Nakagami H, Omi Y, Lee U, Kaneda Y. Cold shock domain protein A (CSDA) overexpression inhibits tumor growth and lymph node metastasis in a mouse model of squamous cell carcinoma. Clin Exp Metastasis 2010, 27(7):539-547. 10.1007/s10585-010-9343-y, 20623179.
25. Jung M, Ramankulov A, Roigas J, Johannsen M, Ringsdorf M, Kristiansen G, Jung K. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol Biol 2007, 8:47. 10.1186/1471-2199-8-47, 1913536, 17559644.
26. Kohno Y, Matsuki Y, Tanimoto A, Izumi H, Uchiumi T, Kohno K, Shimajiri S, Sasaguri Y. Expression of Y-box-binding protein dbpC/contrin, a potentially new cancer/testis antigen. Br J Cancer 2006, 94(5):710-716. 2361212, 16479255.
27. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010, 12(3):247-256. 2845545, 20173740.
28. Rasmussen R. Quantification on the LightCycler. Rapid Cycle Real-Time PCR 2001, 21-34. Springer Berlin Heidelberg: Springerlink, Meuer S, Wittwer C, Nakagawara K-I.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45. 10.1093/nar/29.9.e45, 55695, 11328886.
31. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, Raney BJ, Pohl A, Malladi VS, Li CH, Lee BT, Learned K, Kirkup V, Hsu F, Heitner S, Harte RA, Haeussler M, Guruvadoo L, Goldman M, Giardine BM, Fujita PA, Dreszer TR, Diekhans M, Cline MS, Clawson H, Barber GP, et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 2013, 41(Database issue):D64-D69. 3531082, 23155063.
32. Silver N, Best S, Jiang J, Thein SL. Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol Biol 2006, 7:33. 10.1186/1471-2199-7-33, 1609175, 17026756.
33. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA, de Vries EG, van der Zee AG, te Meerman GJ, ter Elst A. Evidence based selection of housekeeping genes. PLoS One 2007, 2(9):e898. 10.1371/journal.pone.0000898, 1976390, 17878933.
34. Argyrokastritis A, Kontaraki J, Kamakari S, Pasparaki A, Moschonas NK. Assignment of a human cold shock domain protein A intronless pseudogene (CSDAP1) to human chromosome 16 band p11.2 by in situ hybridization. Cytogenet Cell Genet 1999, 84(1-2):53-54.
35. Balakirev ES, Ayala FJ. Pseudogenes: are they " junk" or functional DNA?. Annu Rev Genet 2003, 37:123-151. 10.1146/annurev.genet.37.040103.103949, 14616058.
36. Sellner LN, Turbett GR. The presence of a pseudogene may affect the use of HPRT as an endogenous mRNA control in RT-PCR. Mol Cell Probes 1996, 10(6):481-483. 10.1006/mcpr.1996.0068, 9025089.
37. Mutimer H, Deacon N, Crowe S, Sonza S. Pitfalls of processed pseudogenes in RT-PCR. Biotechniques 1998, 24(4):585-588.
38. Boyle P, Levin B. World Cancer Report 2008 2008, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France: International Agency for Research on Cancer.
39. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994, 7(1):85-90. 10.1038/ng0594-85, 7915601.
40. Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Schmidt LS, Toro JR, Karami S, Hung R, Gerard GF, Linehan WM, Merino M, Zbar B, Boffetta P, Brennan P, Rothman N, Chow WH, Waldman FM, Moore LE. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res 2008, 14(15):4726-4734. 10.1158/1078-0432.CCR-07-4921, 2629664, 18676741.
41. Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruine AP. VHL and HIF signalling in renal cell carcinogenesis. J Pathol 2010, 221(2):125-138. 10.1002/path.2689, 20225241.
42. Arjumand W, Sultana S. Role of VHL gene mutation in human renal cell carcinoma. Tumour Biol 2012, 33(1):9-16. 10.1007/s13277-011-0257-3, 22125026.
43. Choueiri TK, Bukowski RM, Rini BI. The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma. Semin Oncol 2006, 33(5):596-606. 10.1053/j.seminoncol.2006.06.003, 17045089.
44. Albiges L, Salem M, Rini B, Escudier B. Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma. Hematol Oncol Clin North Am 2011, 25(4):813-833. 10.1016/j.hoc.2011.04.006, 21763969.
45. Yao M, Shuin T, Misaki H, Kubota Y. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer. Cancer Res 1988, 48(23):6753-6757.
46. Tang SW, Chang WH, Su YC, Chen YC, Lai YH, Wu PT, Hsu CI, Lin WC, Lai MK, Lin JY. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Cancer Lett 2009, 273(1):35-43. 10.1016/j.canlet.2008.07.038, 18809243.
47. Kozma L, Kiss I, Nagy A, Szakall S, Ember I. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma. Cancer Lett 1997, 111(1-2):127-131.
48. Yamaguchi S, Yoshihiro S, Matsuyama H, Nagao K, Fukunaga K, Matsumoto H, Matsuda K, Oba K, Naito K. The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinoma. Clin Genet 2003, 63(3):184-191. 10.1034/j.1399-0004.2003.00035.x, 12694227.
49. Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, Sellers WR, Meyerson M, Linehan WM, Kaelin WG, Signoretti S. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 2009, 69(11):4674-4681. 10.1158/0008-5472.CAN-09-0146, 2745239, 19470766.
50. Lin BT, Brynes RK, Gelb AB, McCourty A, Amin MB, Medeiros LJ. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study. Mod Pathol 1998, 11(11):1075-1081.
51. Hedberg Y, Davoodi E, Roos G, Ljungberg B, Landberg G. Cyclin-D1 expression in human renal-cell carcinoma. Int J Cancer 1999, 84(3):268-272. 10.1002/(SICI)1097-0215(19990621)84:3<268::AID-IJC12>3.0.CO;2-8, 10371345.
52. Hedberg Y, Ljungberg B, Roos G, Landberg G. Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 2003, 88(9):1417-1423. 10.1038/sj.bjc.6600922, 2741051, 12778072.
53. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007, 11(4):335-347. 10.1016/j.ccr.2007.02.006, 3145406, 17418410.
54. Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B, Simon MC, Nathanson KL. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 2008, 14(6):435-446. 10.1016/j.ccr.2008.10.016, 2621440, 19061835.
55. Bindra RS, Vasselli JR, Stearman R, Linehan WM, Klausner RD. VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells. Cancer Res 2002, 62(11):3014-3019.
56. Baba M, Hirai S, Yamada-Okabe H, Hamada K, Tabuchi H, Kobayashi K, Kondo K, Yoshida M, Yamashita A, Kishida T, Nakaigawa N, Nagashima Y, Kubota Y, Yao M, Ohno S. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor. Oncogene 2003, 22(18):2728-2738. 10.1038/sj.onc.1206373, 12743597.
57. Schuetz AN, Yin-Goen Q, Amin MB, Moreno CS, Cohen C, Hornsby CD, Yang WL, Petros JA, Issa MM, Pattaras JG, Ogan K, Marshall FF, Young AN. Molecular classification of renal tumors by gene expression profiling. J Mol Diagn 2005, 7(2):206-218. 10.1016/S1525-1578(10)60547-8, 1867531, 15858144.
58. Le PU, Nguyen TN, Drolet-Savoie P, Leclerc N, Nabi IR. Increased beta-actin expression in an invasive moloney sarcoma virus-transformed MDCK cell variant concentrates to the tips of multiple pseudopodia. Cancer Res 1998, 58(8):1631-1635.
59. Popow A, Nowak D, Malicka-Blaszkiewicz M. Actin cytoskeleton and beta-actin expression in correlation with higher invasiveness of selected hepatoma Morris 5123 cells. J Physiol Pharmacol 2006, 57(Suppl 7):111-123.
60. Nowak D, Skwarek-Maruszewska A, Zemanek-Zboch M, Malicka-Blaszkiewicz M. Beta-actin in human colon adenocarcinoma cell lines with different metastatic potential. Acta Biochim Pol 2005, 52(2):461-468.
61. Kolahi KS, Mofrad MR. Mechanotransduction: a major regulator of homeostasis and development. Wiley Interdiscip Rev Syst Biol Med 2010, 2(6):625-639. 10.1002/wsbm.79, 20890961.
62. Erdos T, Butler-Browne GS, Rappaport L. Mechanogenetic regulation of transcription. Biochimie 1991, 73(9):1219-1231. 10.1016/0300-9084(91)90007-N, 1747387.
63. Bunnell TM, Burbach BJ, Shimizu Y, Ervasti JM. beta-Actin specifically controls cell growth, migration, and the G-actin pool. Mol Biol Cell 2011, 22(21):4047-4058. 10.1091/mbc.E11-06-0582, 3204067, 21900491.
64. Yasen M, Obulhasim G, Kajino K, Mogushi K, Mizushima H, Tanaka S, Tanaka H, Hino O, Arii S. DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue. Int J Oncol 2012, 40(3):789-797.
65. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971, 68(4):820-823. 10.1073/pnas.68.4.820, 389051, 5279523.
66. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993, 9(4):138-141. 10.1016/0168-9525(93)90209-Z, 8516849.
67. Saito Y, Nakagami H, Kurooka M, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Morishita R, Azuma N, Sasajima T, Kaneda Y. Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element. Oncogene 2008, 27(13):1821-1833. 10.1038/sj.onc.1210824, 17934523.
68. Hu Y, Sun H, Drake J, Kittrell F, Abba MC, Deng L, Gaddis S, Sahin A, Baggerly K, Medina D, Aldaz CM. From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies. Cancer Res 2004, 64(21):7748-7755. 10.1158/0008-5472.CAN-04-1827, 15520179.